Chimeric Antigen Receptor (CAR) T cell therapies have revolutionized cancer treatment—but so far, their success has been largely limited to blood cancers. Solid tumors, which account for around 90% of ...

Scientists at École Polytechnique Fédérale Lausanne (EPFL), and at UNIL-CHUV, University Hospital Lausanne (CHUV) and University of Lausanne (UNIL) have developed a computational method to create ...

Cancer immunotherapy, especially using T cells, is showing a lot of promise in treating blood cancers. Bioengineered T cells, especially those equipped with chimeric antigen receptors (CAR-T cells), ...

Malignant peripheral nerve sheath tumors (MPNSTs) arising from the kidney are rare. The present report describes a renal MPNST of a 33-year-old man exhibiting novel morphological features.

INDIANAPOLIS — New research by the IU School of Medicine is looking at new ways to fight aggressive cancers. Right now the focus is on enhancing treatment options for aggressive cancers like triple ...

LOUISVILLE, Ky. (WDRB) -- Researchers at the Indiana University School of Medicine are developing new ways to fight tumors and aggressive forms of cancer—such as triple-negative breast cancer, ...

OSAKA, Japan & WALTHAM, Mass.--(BUSINESS WIRE)--Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today ...

Using tiny particles shaped like bottlebrushes, MIT chemists have found a way to deliver a large range of chemotherapy drugs directly to tumor cells. To guide them to the right location, each particle ...

Being overweight or obese has long been linked to a greater risk of developing or dying from breast cancer. New research suggests a reason: Certain breast cancer tumors may feed on neighboring fat ...

Efficacy and Safety of Long-Term Continuous Nirogacestat Treatment in Adults With Desmoid Tumors: Results From the DeFi Trial We integrated data from five prospective studies of frontline ...

Transcriptomic Predictors of Survival for Palbociclib + Endocrine Therapy Versus Capecitabine in Aromatase Inhibitor–Resistant Breast Cancer From the GEICAM/2013-02 PEARL Trial Our findings revealed a ...

Ernexa Therapeutics’ “Trojan Horse” stem cells can infiltrate ovarian tumors in mice, boosting T cell activity and leading to shrunken tumors and improved survival, the company announced in a June 2 ...